Biotin (Vitamin B7)

Vitaminoral · inferred

Water-soluble B vitamin important for hair, skin, nails, and fatty acid metabolism. High doses can interfere with laboratory immunoassays.

Projected serum levels — 5k mcg (≈ 5 mg), once daily

Biotin (Vitamin B7)
Biotin (Vitamin B7) modeled serum levels, 5k mcg (≈ 5 mg) once daily over 15 days Population-based pharmacokinetic estimate. Steady state reached after approximately 1 days. 0 0.50 1 1.5 2 Day 0 Day 4 Day 8 Day 11 Day 15 Time on a regular schedule ≈ steady state · day 1

Maintenance schedule: 5k mcg (≈ 5 mg) once daily (oral).

Modeled steady state after ~1 days: peak ≈ 1.3 mg, trough ≈ 0.001 mg body load. Population-based estimate over 15 days for a reference dose at a 70 kg reference body mass — the interactive app scales curves to your doses, timing, and body mass.

Key facts

Category
Vitamin
Route modeled
Oral
Model confidence
inferred
Half-life
1.8 h
Common dose
5k mcg (≈ 5 mg)
Suggested maximum
10k mcg/day
Reference dose range
2.5k–10k mcg (single dose)
Suggested cadence
once daily
Validated against
5 mg oral — Cmax 0.065 mg/L at 1.8 h

Documented interactions

  • warning
    Levothyroxine (Synthroid) + Biotin (Vitamin B7) Potentiation

    High-dose biotin (> 5 mg) interferes with streptavidin-biotin immunoassays used for thyroid testing, causing falsely elevated T4/T3 and falsely suppressed TSH results.

Serum checks 1 modeled interaction pairings for biotin (vitamin b7) across your whole stack — absorption conflicts, enzyme inhibition, and nutrient depletion included.

Research behind this entry

  1. A review of the use of biotin for hair loss Patel DP et al. · Skin Appendage Disorders, 2017 DOI

    Review found limited evidence supporting biotin for hair loss except in cases of actual biotin deficiency, noting most claims are not backed by controlled trials.

  2. Biotin interference with routine clinical immunoassays: understand the causes and mitigate the risks Li D et al. · Clinica Chimica Acta, 2018 DOI

    Important safety review documenting how biotin supplementation can cause falsely abnormal lab results (including thyroid, cardiac, and hormone tests) by interfering with streptavidin-biotin immunoassays.

  3. Bioavailability of biotin given orally to humans in pharmacologic doses. Zempleni J, Mock DM · The American journal of clinical nutrition, 1999 DOI

    This citation reports a human clinical study involving Biotin (Vitamin B7). It does not by itself establish a qualified dose, safety profile, efficacy claim, or pharmacokinetic route for this record.

3 published studies referenced in the app, each with a plain-language summary.